FDA Announces Sweeping Regulations On Tobacco Industry

FDA Announces Sweeping Regulations On Tobacco Industry

The Food and Drug Administration announced a proposal for new policies and regulations against the tobacco industry and e-cigarettes on Thursday. Among the regulations will be a ban on menthol cigarettes and a restriction on the sales of flavored e-cigarettes to convenience stores.

FDA Commissioner Scott Gottlieb said he is enacting the change because of concern stemming from data showing an exponential increase in vaping.

The 2018 National Youth Tobacco Survey found that e-cigarette usage is growing at alarming rates. The survey found that more than 3.6 million middle and high school students used e-cigarettes monthly in 2018, marking an increase of more than 1.5 million students from the previous year.

“I believe these menthol-flavored products represent one of the most common and pernicious routes by which kids initiate on combustible cigarettes,” Gottlieb said in a statement. “The menthol serves to mask some of the unattractive features of smoking that might otherwise discourage a child from smoking.”

Gottlieb said that he would specifically ensure convenience stores not sell flavored e-cigarettes.

“For convenience stores, our goal is to make sure that fruity flavors are not available in those retail sites, period,” he told reporters Thursday.

The cigarette industry has already voiced their concerns with the new regulations, saying they understand the danger of exposing children to smoke products, but that a blanket regulation is unproductive.

“No youth should vape and there is room for more rigorous enforcement to ensure youth are not accessing these products,” said American Vaping Association President Greg Conley in a statement. “However, this move by Commissioner Gottlieb will only serve to make it harder for adult smokers to switch to a far less harmful alternative.”

The Trump administration is gearing up for a long battle against the cigarette industry. It will be difficult for e-cigarette companies to make a compelling case and argue the moral high ground when the data points in favor of the new FDA policies.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s